title: Voriconazole exposure regulates distinct cell-cycle and terminal differentiation pathways in primary human keratinocytes.
authors.affiliation: Department of Dermatology, University of Minnesota, Minneapolis, MN, U.S.A.
authors.forename: M
authors.initials: M
authors.lastname: Mansh
authors.affiliation: Department of Dermatology, University of California, San Francisco, CA, U.S.A.
authors.forename: L
authors.initials: L
authors.lastname: Ing
authors.affiliation: Department of Dermatology, University of California, San Francisco, CA, U.S.A.
authors.forename: M
authors.initials: M
authors.lastname: Dimon
authors.affiliation: Department of Dermatology, University of California, San Francisco, CA, U.S.A.|Dermatology Service, San Francisco Veteran Affairs Medical Center, San Francisco, CA, U.S.A.
authors.forename: A
authors.initials: A
authors.lastname: Celli
authors.affiliation: Department of Dermatology, University of California, San Francisco, CA, U.S.A.|Dermatology Service, San Francisco Veteran Affairs Medical Center, San Francisco, CA, U.S.A.
authors.forename: T M
authors.initials: TM
authors.lastname: Mauro
authors.affiliation: Department of Dermatology, University of California, San Francisco, CA, U.S.A.|Dermatology Service, San Francisco Veteran Affairs Medical Center, San Francisco, CA, U.S.A.
authors.forename: S T
authors.initials: ST
authors.lastname: Arron
mesh_terms: D000935:Antifungal Agents / Q000493:pharmacokinetics*; D002273:Carcinogens / Q000494:pharmacology; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D015870:Gene Expression; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects*; D012878:Skin Neoplasms / Q000139:chemically induced; D065819:Voriconazole / Q000494:pharmacology*
chemical_list: D000935:Antifungal Agents; D002273:Carcinogens; D065819:Voriconazole